DR. Chip Biotechnology Incorporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 14 million compared to TWD 21.06 million a year ago. Net loss was TWD 19.34 million compared to TWD 8.28 million a year ago. Basic loss per share from continuing operations was TWD 0.5 compared to TWD 0.44 a year ago. Diluted loss per share from continuing operations was TWD 0.5 compared to TWD 0.44 a year ago.
For the nine months, sales was TWD 46.39 million compared to TWD 61.39 million a year ago. Net loss was TWD 44.09 million compared to TWD 22.15 million a year ago. Basic loss per share from continuing operations was TWD 1.33 compared to TWD 1.17 a year ago. Diluted loss per share from continuing operations was TWD 1.33 compared to TWD 1.17 a year ago.